Related Experiment Video
Updated: Aug 24, 2026

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
Published on: April 2, 2012
Neonatal herpes simplex virus infection
1University of Alabama at Birmingham, Birmingham, Alabama 35233, USA. rwhitley@peds.uab.edu
Insights
Neonatal herpes simplex virus (HSV) infection outcomes are poor, especially with central nervous system disease. Early detection and high-dose acyclovir treatment improve survival rates for affected infants.
Area of Science:
- Virology
- Neonatal Medicine
- Epidemiology
Background:
- Neonatal herpes simplex virus (HSV) infection poses a significant threat, with poor outcomes despite antiviral therapies.
- Disseminated multi-organ infection and central nervous system disease present particular challenges in neonatal HSV management.
Purpose of the Study:
- To review recent advances impacting the management of neonatal herpes simplex virus infections.
- To highlight updated understanding of transmission, risk factors, and treatment protocols.
Main Methods:
- Review of epidemiological investigations on genital herpes in pregnant women.
- Analysis of treatment outcomes with high-dose acyclovir therapy.
Main Results:
- Identified key risk factors for neonatal HSV, including first-episode maternal infection in the third trimester and invasive monitoring.
- Demonstrated that high-dose acyclovir (20 mg/kg every 8 hours for 21 days) significantly reduces mortality in infants with encephalitis or disseminated disease.
Conclusions:
- Epidemiological studies have identified at-risk pregnancies and methods to decrease maternal-fetal transmission.
- Cesarean delivery can reduce neonatal HSV incidence when maternal infection is present.
- Prompt administration of higher-dose, longer-duration acyclovir is recommended for neonatal HSV disease.
Purpose Of Review:
In spite of the availability of antiviral therapy for the treatment of neonatal herpes simplex virus infections, the outcome remains poor, particularly for babies with disseminated multi-organ infection or central nervous system disease. This review considers recent advances that impact on disease management.
Recent Findings:
Two areas of investigation have impacted on our understanding of neonatal herpes simplex virus infection. First, the transmission of infection from mother to baby has been clarified by extensive epidemiological investigations of genital herpes in pregnant women at term. Risk factors for neonatal herpes simplex virus disease include first-episode maternal infection in the third trimester, invasive monitoring, delivery before 38 weeks, and maternal age of less than 21 years. Regarding the management of neonatal herpes simplex virus disease, the utilization of high-dose acyclovir (20 mg/kg every 8 h) for 21 days significantly reduces mortality for babies with either encephalitis or disseminated disease.
Summary:
Recent findings from epidemiological studies have identified women at risk of delivering a child who develops neonatal herpes simplex virus infection, and suggest methods to decrease maternal-fetal transmission. If infection is identified in the pregnant woman, cesarean delivery decreases the frequency of neonatal disease. With neonatal disease, acyclovir should be administered promptly at higher dosages and for longer periods than previously reported.
Related Concept Videos
Genital Herpes
Herpes
Cytomegalovirus Disease
Chickenpox
Respiratory Syncytial Virus Disease
Encephalitis ll: Pathophysiology

